Polycystic ovary syndrome and its impact on women's quality of life: More than just an endocrine disorder

Drug, Healthcare and Patient Safety

Volumn 1, Issue 1, 2009, Pages 9-15

  Brady, Christine ^a   Mousa, Shaymaa S ^a   Mousa, Shaker A ^a  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Hirsutism; Infertility; Metabolic syndrome; Polycystic ovary syndrome; Psychological distress; Quality of life; Sexual satisfaction

Indexed keywords

CARDIOVASCULAR RISK; CASE MANAGEMENT; CORONARY ARTERY DISEASE; DISTRESS SYNDROME; EARLY DIAGNOSIS; EMOTIONAL STRESS; FEMALE; FEMALE INFERTILITY; HUMAN; METABOLIC SYNDROME X; OVARY POLYCYSTIC DISEASE; QUALITY OF LIFE; REVIEW; SEXUAL SATISFACTION; WOMEN'S HEALTH;

EID: 77953393246     PISSN: None     EISSN: 11791365     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Krysiak R, Okopien B, Gdula-Dymek A, Herman ZS. Update on the management of polycystic ovary syndrome. Pharmacol Rep. 2006;58:614-625.
2. Shroff R, Kerchner A, Maifeld M, Van Beek EJ, Jagasia D, Dokras A. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. J Clin Endocrinol Metab. 2007;92:4609-4614.
3. Jones GL, Benes K, Clark TL, et al. The Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ): a validation. Hum Reprod. 2004;19:371-377.
4. Torpy JM, Lynm C, Glass RM. JAMA patient page. Polycystic ovary syndrome. JAMA. 2007;297:554.
5. Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG. 2006;113:1210-1217.
6. Stankiewicz M, Norman R. Diagnosis and management of polycystic ovary syndrome: a practical guide. Drugs. 2006;66:903-912.
7. Azziz R, Carmina E, Dewailly D, et al. Criteria for defi ning polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab. 2006;91:4237-4245.
8. Hahn S, Janssen OE, Tan S, et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol. 2005;153:853-860.
9. Talbott EO, Guzick DS, Sutton-Tyrrell K, et al. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol. 2000;20:2414-2421.
10. Vural B, Caliskan E, Turkoz E, Kilic T, Demirci A. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Hum Reprod. 2005;20:2409-2413.
11. Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab. 2006;91:492-497.
12. McCook JG, Reame NE, Thatcher SS. Health-related quality of life issues in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs. 2005;34:12-20.
13. Elsenbruch S, Hahn S, Kowalsky D, et al. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88:5801-5807.
14. Coffey S, Bano G, Mason HD. Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36). Gynecol Endocrinol. 2006;22:80-86.
15. Streiner DL, Norman G. Health Measurement Scales: A practical guide to their development and use. 2nd ed. Oxford, UK: Oxford University Press; 2000.
16. Cronin L, Guyatt G, Griffi th L, et al. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab. 1998;83:1976-1987.
17. Eggers S, Kirchengast S. The polycystic ovary syndrome - a medical condition but also an important psychosocial problem. Coll Antropol. 2001;25:673-685.
18. Schmid J, Kirchengast S, Vytiska-Binstorfer E, Huber J. Infertility caused by PCOS - health-related quality of life among Austrian and Moslem immigrant women in Austria. Hum Reprod. 2004;19:2251-2257.
19. Ching HL, Burke V, Stuckey BG. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are signifi cant modifi ers. Clin Endocrinol (Oxf). 2007;66:373-379.
20. Homburg R. What is polycystic ovarian syndrome? A proposal for a consensus on the defi nition and diagnosis of polycystic ovarian syndrome. Hum Reprod. 2002;17:2495-2499.
21. Goldzieher JW, Axelrod LR. Clinical and biochemical features of polycystic ovarian disease. Fertil Steril. 1963;14:631-653.
22. Paulson JD, Haarmann BS, Salerno RL, Asmar P. An investigation of the relationship between emotional maladjustment and infertility. Fertil Steril. 1988;49:258-262.
23. Downey J, Yingling S, McKinney M, Husami N, Jewelewicz R, Maidman J. Mood disorders, psychiatric symptoms and distress in women presenting for infertility evaluation. Fertil Steril. 1989;52:425-432.
24. Azziz R, Marin C, Hoq L, Badamgarav E, Song P. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab. 2005;90:4650-4658.
25. Monga M, Alexandrescu B, Katz SE, Stein M, Ganiats T. Impact of infertility on quality of life, marital adjustment, and sexual function. Urology. 2004;63:126-130.
26. Boivin J, Takefman JE, Tulandi T, Brender W. Reactions to infertility based on extent of treatment failure. Fertil Steril. 1995;63:801-807.
27. Guerra D, Llobera A, Veiga A, Barri PN. Psychiatric morbidity in couples attending a fertility service. Hum Reprod. 1998;13:1733-1736.
28. Oddens BJ, den Tonkelaar I, Nieuwenhuyse H. Psychosocial experiences in women facing fertility problems - a comparative survey. Hum Reprod. 1999;14:255-261.
29. Fekkes M, Buitendijk SE, Verrips GH, et al. Health-related quality of life in relation to gender and age in couples planning IVF treatment. Hum Reprod. 2003;18:1536-1543.
30. Esler DM, Travers CA, Guttikonda K, Dixon A, Lewis PR. The psychosocial experience of women with PCOS - a case control study. Aust Fam Physician. 2007;36:965-967.
31. Weiner CL, Primeau M, Ehrmann DA. Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls. Psychosom Med. 2004;66:356-362.
32. Elsenbruch S, Benson S, Hahn S, et al. Determinants of emotional distress in women with polycystic ovary syndrome. Hum Reprod. 2006;21:1092-1099.
33. Derogatis LR. SCL-90-R: Administration, Scoring and Procedures - Manual II. Baltimore, MD: Clinical Psychometric Research; 1983.
34. Coffey S, Mason H. The effect of polycystic ovary syndrome on health-related quality of life. Gynecol Endocrinol. 2003;17:379-386.
35. Sonino N, Fava GA, Mani E, Belluardo P, Boscaro M. Quality of life of hirsute women. Postgrad Med J. 1993;69:186-189.
36. Amato MC, Galluzzo A, Merlino S, et al. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicillian women with polycystic ovary syndrome. Eur J Endocrinol. 2006;155:859-865.
37. Landay M, Huang A, Azziz R. Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS. Fertil Steril. 2008;Aug 21 [Epub ahead of print].
38. Rabinowitz S, Cohen R, Le Roith D. Anxiety and hirsutism. Psychol Rep. 1983;53(3 Pt 1):827-830.
39. Conn JJ, Jacobs HS. Managing hirsutism in gynaecological practice. Br J Obstet Gynaecol. 1998;105:687-696.
40. Lanigan S, Kwan C, Dykes P, Gonzales M. Quality of life studies in hirsute women receiving ruby laser treatment. Br J Dermatol. 2000;143(Suppl 57):50.
41. Kitzinger C, Willmott J. 'The thief of womanhood': women's experience of polycystic ovarian syndrome. Soc Sci Med. 2002;54:349-361.
42. Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev. 2003;24:302-312.
43. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:1929-1935.
44. Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:48-53.
45. Amato MC, Galluzzo A, Finocchiaro S, Criscimanna A, Giordano C. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome. Clin Endocrinol (Oxf). 2008;69(1):52-60.
46. Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A. Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand. 1992;71:599-604.
47. Solomon CG, Hu FB, Dunaif A, et al. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab. 2002;87:2013-2017.
48. Birdsall MA, Farquhar CM, White HD. Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterisation. Ann Intern Med. 1997;126:32-35.
49. Talbott E, Guzick D, Clerici A, et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol. 1995;15:821-826.
50. Wild S, Pierpoint T, McKeigue P, Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf). 2000;52:595-600.
51. Montague CT, O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes. 2000;49:883-888.
52. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents:fi ndings from the thrid National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157:821-827.
53. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: fi ndings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494-2497.
54. Carmina E, Napoli N, Longo RA, Rini GB, Lobo RA. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the infl uence of criteria for the diagnosis of PCOS. Eur J Endocrinol. 2006;154:141-145.
55. Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS. Epidemiology and adverse cardiovascular risk profi le of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:1357-1363.
56. Lauenborg J, Mathiesen E, Hansen T, et al. The prevalence of the metabolic syndrome in a Danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab. 2005;90:4004-4010.
57. Vignesh JP, Mohan V. Polycystic ovary syndrome: a component of metabolic syndrome? J Postgrad Med. 2007;53:128-134.
58. Rajkhowa M, Neary RH, Kumpatla P, et al. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 1997;82:3389-3394.
59. Kazerooni T, Dehghan-Kooshkghazi M. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome. Gynecol Endocrinol. 2003;17:51-56.
60. Leibel NI, Baumann EE, Kocherginsky M, Rosenfi eld RL. Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome. J Clin Endocrinol Metab. 2006;91:1275-1283.
61. Sir-Petermann T, Maliqueo M, Codner E, et al. Early metabolic derangements in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92:4637-4642.